MindOverMatteR
AI-powered Neuromodulation Therapies for Anxiety Treatment
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in May 2019 by Lilach Roth, MindOverMatteR operated with 1–10 employees, focusing on developing AI-powered neuromodulation therapies. The company ceased operations in May 2022.
Business overview
MindOverMatteR is a bioelectronic medicine startup that develops AI-powered neuromodulation therapies for anxiety treatment. The company integrates advanced neuroscience and technology to provide solutions for insurers, healthcare providers, and employers, aiming to transform anxiety treatment and build resilience while reducing expenses. It operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, leveraging Artificial Intelligence.
Log in to access full profile ›Company Intelligence Q&A
- What is MindOverMatteR's primary focus?
- MindOverMatteR specializes in AI-powered neuromodulation therapies designed for anxiety treatment, integrating advanced neuroscience and technology.
- When was MindOverMatteR founded?
- MindOverMatteR was founded in May 2019.
- Who founded MindOverMatteR?
- MindOverMatteR was founded by Lilach Roth, who also served as CEO.
- What is the operational status of MindOverMatteR?
- MindOverMatteR is non-active and ceased operations in May 2022.
- Which markets does MindOverMatteR target?
- MindOverMatteR targets insurers, healthcare providers, and employers within the healthcare and life sciences sector.